Full-Time

Biomedical Equipment Technician II

Deadline 6/29/27
Fred Hutchinson Cancer Center

Fred Hutchinson Cancer Center

1,001-5,000 employees

Nonprofit cancer treatment, research, and trials

Compensation Overview

$33.42 - $50.12/hr

No H1B Sponsorship

Seattle, WA, USA

In Person

On-site at South Lake Union Campus.

Category
Biology & Biotech

Get referred to Fred Hutchinson Cancer Center

See people who can refer or advise you

Requirements
  • An Associates' Degree in Biomedical Technology -OR- Equivalent education and experience -OR- Certification by the Association for the Advancement of Medical Instrumentation (AAMI) as a candidate.
  • Three years of relevant experience maintaining and repairing biomedical equipment.
  • Basic troubleshooting skills.
  • Knowledge of specialized test equipment such as electrical safety analyzers, patient simulators, and device specific test instruments.
  • Ability to use basic hand and power tools.
  • Telephone operation and courtesy skills.
  • Customer service skills.
Responsibilities
  • Under general supervision, independently troubleshoot, repair, maintain and calibrate all electronic/mechanical/hydraulic patient care, life support, surgical services, and clinical laboratory equipment, apparatus or systems such as but not limited to cardiac monitors, bed side patient monitoring systems, electrosurgical unit (ESU), blood-gas analyzers, multi-chemistry analyzers, surgical lasers, general/basic imaging equipment (portable X-ray machines), surgical robots, and infusion device
  • Perform preventative maintenance by cleaning, lubricating, adjusting, calibrating, verifying performance and electrical safety testing.
  • Document equipment inspections, repairs and failures in database.
  • Confer with faculty, staff, health care providers, laboratory staff, vendors and management to resolve equipment problems.
  • Drive Fred Hutch owned vehicles to service equipment at community sites.
  • Evaluate, make recommendations, and approve devices for use on human subjects.
  • Reviews outcome of preventive maintenance actions and make recommendations for improvements to processes or procedures.
  • Repair malfunctioning patient care life support equipment
  • Evaluate medical equipment involved in unusual incidents and prepare reports and documentation.
  • Provide mentorship to other technicians
  • Other related duties as assigned
Desired Qualifications
  • An Associates' Degree in Biomedical Technology.
  • Three years of experience in a hospital or outpatient clinical engineering environment.
  • Three years of experience in a hospital or outpatient clinical engineering environment.
  • Knowledge of software applications including manufacturer's service tools, computerized maintenance management systems, databases, dashboards, spreadsheets, and other metrics-based monitoring systems including asset management systems.
Fred Hutchinson Cancer Center

Fred Hutchinson Cancer Center

View

Fred Hutchinson Cancer Center is a nonprofit cancer treatment and research institute serving the Pacific Northwest and beyond. It provides a full range of cancer care, including treatments that may not be available elsewhere, and offers patients the chance to participate in clinical trials. The center accomplishes its work through a combination of patient care, research grants, and fundraising, and collaborates with UW Medicine and other regional providers to extend its reach. Internationally, it operates facilities in Uganda and South Africa to advance research and collaboration. The organization’s revenue comes from patient services, grants, and fundraising events. Its central goal is to eliminate cancer and related diseases by improving treatments and ultimately finding a cure.

Company Size

1,001-5,000

Company Stage

Grant

Total Funding

$300K

Headquarters

Seattle, Washington

Founded

1975

Get referred to Fred Hutchinson Cancer Center

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Large grant-funded research engine supports translational science and clinical trials.
  • Clinically integrated with UW Medicine, expanding referrals and care coordination.
  • Community fundraising and donor support can finance high-risk, high-reward projects.

What critics are saying

  • Heavy dependence on federal research funding exposes programs to budget cuts.
  • Seattle concentration creates operational disruption risk from local shocks or labor actions.
  • Partnership dependence on UW Medicine makes referral flow vulnerable to coordination failures.

What makes Fred Hutchinson Cancer Center unique

  • Pioneering nonprofit cancer center integrating research, care, and infectious disease work.
  • NCI-recognized Fred Hutch, UW, and Seattle Children's cancer consortium.
  • Global research footprint includes Seattle, Uganda, and South Africa.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Paid Vacation

Paid Sick Leave

Paid Holidays

Paid Parental Leave

Sabbatical Leave

Tuition Reimbursement

Company News

Ensoma
Jul 16th, 2026
Ensoma Launches to Pioneer Next-Generation In Vivo Approach to Deliver First “Off-the-shelf” Genomic Medicines

Company’s Engenious™ Vectors Delivered without Stem Cell Collection or Myeloablative Conditioning in Outpatient and Low-resource Settings, Enabling Access Worldwide

GeekWire
Apr 17th, 2025
Tech Moves: Smartsheet Names Chief Product Officer; Meta Vet Joins Tech Alliance; And More

Tech Moves covers notable hires, promotions and personnel changes in the Pacific NW tech community. Submissions: [email protected] Arora. (Smartsheet Photo)— Pratima Arora has been named chief product officer at Smartsheet, a new senior executive role at the Bellevue, Wash.-based enterprise software giant.A longtime product and technology leader, Arora will be responsible for Smartsheet’s product management, product marketing, user experience, pricing and packaging, and digital and product partnerships.She previously held senior leadership roles at Atlassian and Salesforce, and was most recently the chief product and technology officer at Chainalysis.“After a fantastic 4-month break to recharge, spend quality time with family, and dive deep into the world of GenAI, I’m energized and ready for what’s next,” Arora said on LinkedIn. “There’s no better place than Smartsheet to begin this new chapter. With a strong foundation, a passionate customer base, and a unique opportunity to reimagine collaborative work through AI, the road ahead is full of possibility.”Smartsheet also announced that Nick Dunn, an eight-year veteran of the company, is now general counsel, responsible for leading the company’s legal, privacy, and risk functions, including corporate governance initiatives.Launched in 2005, Smartsheet makes cloud-based enterprise work management technologies for managing and tracking projects, collaborating, storing data, and automating and assigning tasks, among other capabilities. It serves 85% of the Fortune 500 as customers

PR Newswire
Apr 4th, 2025
Google Cloud And Ai2 Commit $20M To Advance Ai-Powered Research For The Cancer Ai Alliance

Google Cloud to provide advanced and secure technology, while Ai2 to lead AI training and development for AI cancer modelsSEATTLE and SUNNYVALE, Calif., April 4, 2025 /PRNewswire/ -- Today, Google Cloud and Ai2 announced they have partnered with the Cancer AI Alliance (CAIA), a pioneering consortium uniting leading cancer research institutions and technology companies to harness artificial intelligence (AI) in the fight against cancer. Google Cloud and Ai2 are each giving $10 million to the initiative and providing access to technology solutions that will help speed scientific discovery. Google Cloud will power planet-scale AI infrastructure and data analytics tools, while Ai2 will provide critical expertise in training large-scale models focusing on cancer research

GeekWire
Apr 4th, 2025
Ai2 And Google Cloud Join Cancer Ai Alliance With A Total Of $20M In Commitments

Inside the Allen Institute for AI in Seattle. (GeekWire File Photo / Todd Bishop)The Allen Institute for AI (Ai2) is joining a high-profile national effort to accelerate cancer research using artificial intelligence, committing $10 million in researcher time and technical expertise to the Cancer AI Alliance, a consortium led by the Fred Hutch Cancer Center.Google Cloud is also committing $10 million in resources to the effort, planning to provide computing infrastructure and tools to help process large volumes of cancer data. They say the goal is to create a novel AI infrastructure that supports the training and deployment of AI models across institutions while maintaining data security and privacy standards for patients.The Cancer AI Alliance was announced in October 2024 as a joint effort among four major cancer centers: Fred Hutch, Dana-Farber, Memorial Sloan Kettering, and Johns Hopkins. Backed by more than $40 million in initial support from AWS, Microsoft, NVIDIA, Deloitte, and Slalom, the project aims to use artificial intelligence to analyze large volumes of cancer data across institutions. Seattle-based Fred Hutch is serving as the lead coordinating center.Ai2 CEO Ali Farhadi in his Seattle office. (GeekWire File Photo / Todd Bishop)In a previous interview with GeekWire, Ai2 CEO Ali Farhadi said the Cancer AI Alliance represents the kind of real-world challenge that needs customized, domain-specific AI models. The Seattle-based AI institute focuses on open-source artificial intelligence technologies.Farhadi said Ai2’s role in the Cancer AI Alliance reflects Ai2’s goal to apply cutting-edge research where it can have the most tangible impact on the world.“Any step in the right direction in that space is going to be a risk worth taking, and that’s the kind of impact that we’re after,” Farhadi said, explaining Ai2’s ambitions for 2025 on the GeekWire Podcast. “If you’re actually trying to solve a real problem, there is no turnkey solution.”The Cancer AI Alliance has said it expects initial research results by the end of 2025

GeekWire
Mar 18th, 2025
Geekwire Awards: Health Innovation Of The Year Field Is Dominated By Finalists Battling Cancer

The 2025 GeekWire Award finalists for Health Innovation of the Year are dominated by ventures that aim to outwit cancer with groundbreaking new technologies. The contenders range from a newly formed startup to a leading U.S. cancer institute and companies in between. Joining the cohort is a business with technology to help healthcare providers better manage appointments and access to providers.This awards category recognizes pioneering health, life science, biotechnology or medical breakthroughs that hold great promise for improving peoples’ lives and enhancing the healthcare system.The finalists are Archon Biosciences, DexCare, Fred Hutch Cancer Center, Talus Bioscience and Umoja Biopharma.Last year’s winner was CalmWave, a Seattle health-tech startup that created a system for making sense of the alarms triggered by the devices that monitor hospital ICU patients.Continue reading for details on each of this year’s finalists, and vote here or below.Archon BiosciencesArchon Biosciences emerged from stealth last October with $20 million in funding. The Seattle biotech company is running with technology developed in the lab of University of Washington biochemist and Nobel Prize winner David Baker.Archon’s proprietary protein structures, known as Antibody Cages or AbCs, combine two biomedical tools — naturally occurring antibodies and custom-designed proteins — to create a single new protein structure. These protein structures, or AbCs, are optimized with the aid of generative AI to travel in the body in controllable ways and engage with target cells in a more specific manner.“What we like to say is, it’s not whether you’re given a drug, it’s how you’re given it,” said CEO and co-founder James Lazarovits